When I sat down to record this episode of the GLP-1 Collective Podcast, I knew we were in for something special. Dr. Craig Primack, MD, FACP, FAAP, MFOMA, is a leader in obesity medicine, and honestly, he has so many accomplishments that I had to list them in bullet points.

I’m sure I’m still missing a few, but here’s just a glimpse:

* Co-founder of Scottsdale Weight Loss Center in Arizona, a multi-location practice serving thousands.

* Served on the board of the Obesity Medicine Association from 2010 through 2024.

* President of the OMA from 2019 to 2021.

* Frequent media guest and national speaker on obesity care.

* Co-author of Chasing Diets and widely published in the field.

In addition to his own practice, Dr. Primack works as the Head of Weight Loss at Hims & Hers to help expand access to comprehensive care for those who might not otherwise be able to access it.

White Paper: The Key Takeaways

The main reason Dr. Primack joined me was to share data from a new white paper from his work with Hims & Hers. This first-of-its-kind analysis gives us a real look at how a more personalized approach to care through digital health is changing obesity medicine and what it means for patients right now.

Full disclosure: I’ve never been a Hims & Hers patient, I’m not an affiliate, and I wasn’t paid to share this information or conduct this interview. But without telehealth, I know I’d still be stuck in the exhausting cycle of ‘eat less, move more,’ so I’m forever grateful for telehealth as a whole and glad I had the chance to learn about these findings and share them.

Here are some of the key findings:

* Telehealth Impact: Patients accessing personalized GLP-1 treatment plans through Hims & Hers lost an average of 20 pounds, or about 10 percent of their body weight, in six months. That is medically significant weight loss with proven metabolic benefits.

* Access Improvement: Instead of waiting months to see one of the fewer than 10,000 obesity specialists in the U.S., patients were able to start treatment in a matter of days.

* Comprehensive Care: The Hims & Hers approach is not just about prescribing a GLP-1. Patients receive nutrition tools, movement guidance, education, and 24/7 provider messaging, all of which contributed to a dropout rate of just 25 percent at six months. In contrast, dropout rates for

commercially available GLP-1s can hover around 80% at six

months.

In a nutshell, this white paper analysis shows that digital health isn’t just convenient. It’s delivering real outcomes, keeping people on treatment, and reshaping how we think about obesity care.

Hims & Hers Details

As a GLP-1 freelance writer, I often review telehealth companies. This is my personal observation, not an endorsement. I’m not affiliated with Hims & Hers, and this isn’t a paid review. I’m not breaking down too many details here, since this isn’t a paid telehealth review and that level of depth belongs in my freelance work but I will share some of the highlights that we covered during the interview for anyone interested in learning more.

Here are the details:

* Pricing: I found Hims & Hers pricing to be very competitive compared to other options.

* 24/7 Messaging: patients have continuous access to licensed providers through the app. This means you can get guidance on side effects, dosage, or general concerns from a legitimate provider, without waiting for a call back from your doctor’s office.

* Comprehensive Resources: an app that includes protein trackers, recipes, behavioral education, and lifestyle coaching.

* Personalized Dosing: Hims & <a href="https://www.forhers.com/?utm_source=google&utm_